Publikationen suchen
- Publikation
- Autoren
- Einrichtungen
- Abstract
- Externe Dokumente
- Links
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)
(
Zeitschriftenartikel
)